General MedicationsINJECTIONStandard
ABRILADA
ADALIMUMAB-AFZB
Standard Dose
20MG/0.4ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview ABRILADA is listed in Drugs@FDA under application 761118 (BLA).
Review priority: STANDARD Marketing status: Prescription Active ingredient ADALIMUMAB-AFZB Form and strength INJECTABLE;INJECTION - 20MG/0.4ML Sponsor PFIZER INC Submission history Latest submission status date: 2025-12-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview ABRILADA is listed in Drugs@FDA under application 761118 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient ADALIMUMAB-AFZB Form and strength INJECTABLE;INJECTION - 20MG/0.4ML Sponsor PFIZER INC Submission history Latest submission status date: 2025-12-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.